Konstantinos N Fountoulakis is an expert in Psychiatry at AHEPA University Hospital (Greece). As of October 2026, ScienceLeadR ranks Konstantinos N Fountoulakis in the top 1% of experts in Greece for Bipolar Disorder and Bipolar and Related Disorders. Konstantinos N Fountoulakis has authored 438 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,447 (community average: 125). How the SLR is computed.

LeadR Profile

Konstantinos N Fountoulakis AHEPA University Hospital Greece
1 447 ScienceLeadR Reputation 1447
Network Map

Psychiatry

Subspecialties: Pharmacy - Neurology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1998 - 2026

Source: PubMed

Aristotle University of Thessaloniki

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 438

Citations

Citations: 13 515 1st author: 185 Last author: 75 Unique author: 51


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Transdiagnostic determinants of Growth Differentiation Factor-15 (GDF-15) in psychiatric in-patients: age, renal indices, interleukin-6 (IL-6) and soluble urokinase plasminogen activator receptor (suPAR).
PMID 42577004 — growth, plasminogen, urea, plasminogen activators, stress, physiological, c-reactive protein, growth differentiation factor 15, interleukin-6, urokinase-type plasminogen activator, diagnosis, receptors, urokinase plasminogen activator
Brain Behav Immun Health20260
A critical synthesis of treatment guidelines for schizophrenia.
PMID 42459578 — schizophrenia, therapeutics
Dusunen Adam20250
A Schizophrenia-Spectrum Presentation with Panda Sign: Huntington's Disease Confirmed, Wilson Disease Excluded.
PMID 42178294 — genetic testing, schizophrenia, hepatolenticular degeneration, huntington disease
Mov Disord Clin Pract20260
Neurocognitive changes in lithium-treated older adult bipolar patients on antipsychotics.
PMID 42116740 — neuropsychological tests, neuroprotection, antipsychotic agents, therapeutics, memory, cognition
J Psychopharmacol20260
Late-onset major depression and subthreshold depressive symptoms as early clinical correlates of brain small vessel disease.
PMID 42102124 — depression, stroke, brain, signs and symptoms
Int J Neuropsychopharmacol20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Terminated 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map